Cigna Group
For the period ended Sep 30, 2025. Filed Oct 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 30, 2025
CI$295.60+0.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| The Cigna GroupConsolidated Balance Sheets | ||
|---|---|---|
| Unaudited | ||
| As of September 30, | As of December 31, | |
| (In millions) | 2025 | 2024 |
| Assets | ||
| Cash and cash equivalents | $6,025 | $7,550 |
| Investments | 883 | 665 |
| Accounts receivable, net | 31,709 | 24,227 |
| Inventories | 5,632 | 6,692 |
| Other current assets | 2,486 | 2,732 |
| Assets of businesses held for sale | — | 7,004 |
| Total current assets | 46,735 | 48,870 |
| Long-term investments | 18,483 | 15,128 |
| Reinsurance recoverables | 4,207 | 4,378 |
| Property and equipment | 3,650 | 3,654 |
| Goodwill | 44,924 | 44,370 |
| Other intangible assets | 28,975 | 29,417 |
| Other assets | 3,389 | 2,786 |
| Separate account assets | 7,556 | 7,278 |
| TOTAL ASSETS | $157,919 | $155,881 |
| Liabilities | ||
| Current insurance and contractholder liabilities | $6,018 | $5,388 |
| Pharmacy and other service costs payable | 30,301 | 28,465 |
| Accounts payable | 9,346 | 9,294 |
| Accrued expenses and other liabilities | 7,695 | 9,387 |
| Short-term debt | 3,093 | 3,035 |
| Liabilities of businesses held for sale | — | 2,410 |
| Total current liabilities | 56,453 | 57,979 |
| Non-current insurance and contractholder liabilities | 10,079 | 10,254 |
| Deferred tax liabilities, net | 6,997 | 6,975 |
| Other non-current liabilities | 3,873 | 3,215 |
| Long-term debt | 30,947 | 28,937 |
| Separate account liabilities | 7,556 | 7,278 |
| TOTAL LIABILITIES | 115,905 | 114,638 |
| Shareholders' equity | ||
| Common stock (1) | 4 | 4 |
| Additional paid-in capital | 31,698 | 31,288 |
| Accumulated other comprehensive loss | (2,799) | (2,341) |
| Retained earnings | 47,028 | 43,519 |
| Less: Treasury stock, at cost | (34,126) | (31,437) |
| TOTAL SHAREHOLDERS' EQUITY | 41,805 | 41,033 |
| Noncontrolling interests | 209 | 210 |
| Total equity | 42,014 | 41,243 |
| Total liabilities and equity | $157,919 | $155,881 |
(1)Par value per share, $0.01; shares issued,404 million as of September 30, 2025 and 403 million as of December 31, 2024; authorized shares,600 million.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.